Dipeptidyl peptidase-4 inhibitors may lower body temperature: A case-control study

Dipeptidyl peptidase-4 inhibitors (DPP4i) enhance GABAergic transmission via the glucagon-like peptide-1 (GLP-1)/GLP-1 receptor pathway. Oral γ-aminobutyric acid (GABA) administration reduces body temperature in humans; thus, DPP4i may reduce body temperature in humans. Therefore, this study aimed t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes & metabolic syndrome clinical research & reviews 2024-10, Vol.18 (10), p.103142, Article 103142
Hauptverfasser:	Okada, Shuichi, Okada, Kazuya, Okada, Junichi, Kikkawa, Koji, Yamada, Eijiro, Saito, Tsugumichi, Andou, Tetsuro, Ohshima, Kihachi, Niijima, Yawara
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biomarkers - analysis Blood Glucose - analysis Body temperature Body Temperature - drug effects Case-Control Studies Diabetes Mellitus, Type 2 - drug therapy Dipeptidyl peptidase-4 inhibitor Dipeptidyl-Peptidase IV Inhibitors - therapeutic use Female Follow-Up Studies Humans Male Middle Aged Prognosis Type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!